Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series report

Antipsychotic long-acting formulations (LAI-AP) have emerged as a new therapeutic choice to treat patients presenting a severe mental disorder. Despite that, to date, there is a lack of safety data and studies regarding the use of LAI-AP formulations in pregnant women. Here we present the first six-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Abascal, Blanca, Recio-Barbero, Maria, Sáenz-Herrero, Margarita, Segarra, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851104/
https://www.ncbi.nlm.nih.gov/pubmed/35186259
http://dx.doi.org/10.1177/2045125321991277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851104/
https://www.ncbi.nlm.nih.gov/pubmed/35186259
http://dx.doi.org/10.1177/2045125321991277

Ejemplares similares